Radiology 2020 11 8;297(2):327-333. Epub 2020 Sep 8.
From the Department of Medical Epidemiology and Biostatistics (M.E., K.C., P.H.) and Department of Oncology-Pathology (F.S.), Karolinska Institutet, Nobelsv 12A, Stockholm 171 77, Sweden; Department of Breast Radiology, Karolinska University Hospital, Stockholm, Sweden (F.S.); Department of Diagnostic Radiology, Lund University, Skåne University Hospital Malmö, Sweden (S.Z., K.L., D.F., H.S.); Department of Thoracic Radiology, Imaging and Physiology and Department of Physiology and Pharmacology, Karolinska Hospital, Stockholm, Sweden (P.L.); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care (N.M., D.E.) and Department of Oncology (D.E.), University of Cambridge, Cambridge, England; and Department of Oncology, Södersjukhuset, Stockholm, Sweden (P.H.).
Background Mammography screening reduces breast cancer mortality, but a proportion of breast cancers are missed and are detected at later stages or develop during between-screening intervals. Purpose To develop a risk model based on negative mammograms that identifies women likely to be diagnosed with breast cancer before or at the next screening examination. Materials and Methods This study was based on the prospective screening cohort Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA), 2011-2017. Read More